Protective action of vitamins on the spermatogenesis in lead-treated Swiss mice.
The protective action of vitamins C and E against lead acetate-induced reduced sperm count and sperm abnormalities in Swiss mice has been studied. Intraperitoneal injection of lead acetate (10mg/kg body weight) in the present study stimulates lipid peroxidation in the testicular tissue, indicated by a significant increase in malondialdehyde content in the experimental mice group. This is associated with an increased generation of noxious reactive oxygen species (ROS). Significantly reduced sperm count associated with increased sperm abnormality percentage in the lead-injected mice group compared to controls substantially proves the ongoing damaging effects of lead-induced ROS on developing germ cells. However, intraperitoneal administration of vitamin C (Vit C) at a concentration equivalent to the human therapeutic dose (10 mg/kg body weight) was able to minimize significantly the testicular malondialdehyde content with a concomitant increase in sperm count and significant decrease in the percentage of abnormal sperm population. Vitamin E (Vit E) (100 mg/kg body weight) treatment of a batch of lead-injected mice had a similar effect as Vit C but with a comparatively lower efficacy. On the other hand, coadministration of both vitamins (Vit C + Vit E) at the above mentioned doses to lead-treated mice led to the most significant decline in malondialdehyde content along with elevated sperm count and reduction in the percentage of abnormal sperm population. The protective action and the synergistic action of both vitamins (C and E) against lead-induced genotoxicity are discussed.
Mishra
Monalisa
M
Department of Zoology, Berhampur University, Orissa 760001, India.
Acharya
Usha R
UR
D000818:Animals; D001205:Ascorbic Acid / Q000627:therapeutic use*; D007855:Lead Poisoning / Q000188:drug therapy / Q000503:physiopathology*; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D051379:Mice; D009929:Organ Size; D009942:Organometallic Compounds; D017382:Reactive Oxygen Species / Q000378:metabolism; D013076:Sperm Count; D013091:Spermatogenesis / Q000187:drug effects*; D013094:Spermatozoa / Q000002:abnormalities / Q000187:drug effects; D013737:Testis / Q000187:drug effects / Q000473:pathology; D024502:alpha-Tocopherol / Q000627:therapeutic use*
D009942:Organometallic Compounds; D017382:Reactive Oxygen Species; D024502:alpha-Tocopherol; D001205:Ascorbic Acid; C008261:lead acetate